Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study

INTRODUCTION: The glycopeptide teicoplanin is commonly utilized to facilitate outpatient parenteral antimicrobial therapy (OPAT). Licensed for once daily maintenance dosing, teicoplanin’s long half-life allows for less frequent dosing (e.g. thrice weekly) following successful loading. This service e...

Descripción completa

Detalles Bibliográficos
Autores principales: Asumang, John, Heard, Katie L, Troise, Oliver, Fahmy, Sandra, Mughal, Nabeela, Moore, Luke S P, Hughes, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210249/
https://www.ncbi.nlm.nih.gov/pubmed/34223089
http://dx.doi.org/10.1093/jacamr/dlab012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210249/
https://www.ncbi.nlm.nih.gov/pubmed/34223089
http://dx.doi.org/10.1093/jacamr/dlab012

Ejemplares similares